312 related articles for article (PubMed ID: 35668943)
1. Berberine: A Promising Treatment for Neurodegenerative Diseases.
Cheng Z; Kang C; Che S; Su J; Sun Q; Ge T; Guo Y; Lv J; Sun Z; Yang W; Li B; Li X; Cui R
Front Pharmacol; 2022; 13():845591. PubMed ID: 35668943
[TBL] [Abstract][Full Text] [Related]
2. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.
Fan D; Liu L; Wu Z; Cao M
Curr Neuropharmacol; 2019; 17(6):563-579. PubMed ID: 29676231
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
4. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
[TBL] [Abstract][Full Text] [Related]
5. Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer's Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress.
Liang Y; Ye C; Chen Y; Chen Y; Diao S; Huang M
ACS Chem Neurosci; 2021 Jun; 12(11):1894-1904. PubMed ID: 33983710
[TBL] [Abstract][Full Text] [Related]
6. Can Berberine Serve as a New Therapy for Parkinson's Disease?
Dadgostar E; Moghanlou M; Parvaresh M; Mohammadi S; Khandan M; Aschner M; Mirzaei H; Tamtaji OR
Neurotox Res; 2022 Aug; 40(4):1096-1102. PubMed ID: 35666433
[TBL] [Abstract][Full Text] [Related]
7. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Sahu K; Singh S; Devi B; Singh C; Singh A
Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
[TBL] [Abstract][Full Text] [Related]
8. Berberine and neurodegeneration: A review of literature.
Ahmed T; Gilani AU; Abdollahi M; Daglia M; Nabavi SF; Nabavi SM
Pharmacol Rep; 2015 Oct; 67(5):970-9. PubMed ID: 26398393
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases.
Islam F; Islam MM; Khan Meem AF; Nafady MH; Islam MR; Akter A; Mitra S; Alhumaydhi FA; Emran TB; Khusro A; Simal-Gandara J; Eftekhari A; Karimi F; Baghayeri M
Chemosphere; 2022 Nov; 307(Pt 3):136020. PubMed ID: 35985383
[TBL] [Abstract][Full Text] [Related]
10. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.
Kulkarni SK; Dhir A
Phytother Res; 2010 Mar; 24(3):317-24. PubMed ID: 19998323
[TBL] [Abstract][Full Text] [Related]
11. The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation.
Karvandi MS; Sheikhzadeh Hesari F; Aref AR; Mahdavi M
Front Cell Neurosci; 2023; 17():1105247. PubMed ID: 36950516
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders.
Devi S; Kumar V; Singh SK; Dubey AK; Kim JJ
Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33498503
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.
Akbar M; Shabbir A; Rehman K; Akash MSH; Shah MA
J Food Biochem; 2021 Oct; 45(10):e13936. PubMed ID: 34523148
[TBL] [Abstract][Full Text] [Related]
14. Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells.
Sadeghnia HR; Kolangikhah M; Asadpour E; Forouzanfar F; Hosseinzadeh H
Iran J Basic Med Sci; 2017 May; 20(5):594-603. PubMed ID: 28656094
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases.
Teleanu DM; Niculescu AG; Lungu II; Radu CI; Vladâcenco O; Roza E; Costăchescu B; Grumezescu AM; Teleanu RI
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682615
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.
Cassano T; Calcagnini S; Pace L; De Marco F; Romano A; Gaetani S
Front Neurosci; 2017; 11():30. PubMed ID: 28210207
[TBL] [Abstract][Full Text] [Related]
17. Berberine: Pathways to protect neurons.
Lin X; Zhang N
Phytother Res; 2018 Aug; 32(8):1501-1510. PubMed ID: 29732634
[TBL] [Abstract][Full Text] [Related]
18. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms.
Sadraie S; Kiasalari Z; Razavian M; Azimi S; Sedighnejad L; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
Metab Brain Dis; 2019 Feb; 34(1):245-255. PubMed ID: 30456649
[TBL] [Abstract][Full Text] [Related]
19. Role of berberine in Alzheimer's disease.
Cai Z; Wang C; Yang W
Neuropsychiatr Dis Treat; 2016; 12():2509-2520. PubMed ID: 27757035
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
